CpG 10101
Alternative Names: Actilon; CpG-10101Latest Information Update: 02 Oct 2021
At a glance
- Originator Coley Pharmaceutical Group
- Class Antivirals; Oligonucleotides
- Mechanism of Action Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 04 Aug 2009 No development reported - Phase-II for Hepatitis C in USA (SC)
- 01 Jan 2008 Coley Pharmaceutical Group has been acquired by Pfizer
- 22 Jan 2007 CpG 10101 is available for licensing (http://www.coleypharma.com)